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Cord Blood 25-hydroxyvitamin D 
and Fetal Growth in the China-
Anhui Birth Cohort Study
Peng Zhu1,2,3, Shi-lu Tong1,3, Wen-biao Hu3, Jia-hu Hao1,2, Rui-xue Tao4, Kun Huang1,2, 
Zhe Mou5, Qi-fan Zhou1, Xiao-min Jiang6 & Fang-biao Tao1,2
We determined the association of cord blood 25-hydroxyvitamin D [25(OH)D] with birth weight and 
the risk of small for gestational age (SGA). As part of the China-Anhui Birth Cohort (C-ABC) study, 
we measured cord blood levels of 25(OH)D in 1491 neonates in Hefei, China. The data on maternal 
sociodemographic characteristics, health status, lifestyle, birth outcomes were prospectively 
collected. Multiple regression models were used to estimate the association of 25(OH)D levels with 
birth weight and the risk of SGA. Compared with neonates in the lowest decile of cord blood 25(OH)
D levels, neonates in four deciles (the fourth, fifth, sixth and seventh deciles) had significantly 
increased birth weight and decreased risk of SGA. Multiple linear regression models showed that 
per 10 nmol/L increase in cord blood 25(OH)D, birth weight increased by 61.0 g (95% CI: 31.9, 89.9) 
at concentrations less than 40 nmol/L, and then decreased by 68.5 g (95% CI: −110.5, −26.6) at 
concentrations from 40 to 70 nmol/L. This study provides the first epidemiological evidence that there 
was an inverted U shaped relationship between neonatal vitamin D status and fetal growth, and the 
risk of SGA reduced at moderate concentration.
Growth restriction in utero increases infant morbidity and mortality as well as the risk of adult chronic 
diseases1–3. The incidence of fetal growth restriction in both developed and developing countries pro-
gressively rose during the last two decades despite the introduction of many public health and medical 
interventions designed to reduce its occurrence4–6. Whether the common vitamin D deficiency during 
pregnancy contributes to any of the global adverse fetal growth epidemic remains unknown.
Maternal vitamin D deficiency during pregnancy is a significant public health problem globally7,8 due 
to the combined effects of limited sunlight exposure, inadequate intake, and additional growth needs of 
the fetus. The link between maternal vitamin D status and fetal growth, as measured most frequently by 
infant birth weight and small for gestational age (SGA), has been explored by a number of observational 
studies9–15 and randomized supplementation trials16–20 worldwide with mixed results.
Most studies assessed the associations of maternal 25-hydroxyvitamin D (25[OHD]) in early preg-
nancy with fetal growth. Evidences from some studies support the hypothesis that lower vitamin D status 
causes adverse fetal growth in a linear way, more severe deficiency would be expected to have a stronger 
effect than less severe deficiency or sufficiency9,10,12–14,16. However, some other studies don’t support this 
hypothesis15,18,19,21,22. The conflicting findings may be due to variations of study designs including the ges-
tational weeks of vitamin D testing, the cut-point of vitamin D, ethnicity of the study population, genetic 
variation and outcome variables. The translation of these findings to clinical practice has not occurred.
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Notably, increased risks for a range of health outcomes, including SGA, among pregnant women 
with high 25(OH)D levels has been reported by several studies11,23. Although fetal and newborn concen-
trations of 25(OH)D depend on and correlate with maternal serum levels18,24, there has been a paucity 
of data about the association between cord blood 25(OH)D concentration and birth outcomes. In this 
study, we examined cord blood levels of 25(OH)D in 1491 neonates in Hefei, China and assessed the 
association of cord blood levels of 25(OH)D with birth weight and the risk of SGA.
Results
Attrition analyses showed the distributions of sociodemographic characteristics, health status, lifestyle 
and birth outcomes, non-participants did not differ from participants. In this study, the mean age of 
the participants was 27.65 years (SD = 3.66), the majority (79.2%) of participants had completed high 
school and beyond (> 9 years), and the income of 84.9% of the participants was more than 2 000 RMB 
per month. The mean gestational age at delivery was 38.91 weeks (SD = 1.47), ranging from 32 to 42 
weeks, with 96 preterm births (5.3%). The mean birth weight was 3383.1 g (SD = 453.9), ranging from 
1500 to 5500 g, with 133 small for gestational age infants (8.9%). In our sample, 791 (53.1%) newborns 
were males. The mean cord blood 25(OH)D level was 39.43 nmol/L (SD = 20.35), ranged from 6.06 to 
119.64. Table 1 shows the characteristics of 1 491 pregnant women across increasing deciles of cord blood 
25-hydoxyvitamin D levles. With increasing deciles of cord blood 25(OH)D, the percentage of birth 
during summer to autumn and male infant increased (P < 0.05 for the trend). Male infants had slightly 
higher cord blood 25(OH)D levels than females, but the difference did not reach statistical significance 
after adjusting for the season of birth (P = 0.11).
Table  2 shows the associations between socio-demographic characteristics, lifestyle variables, birth 
related variables and baby’s birth weight. Factors that were significantly associated with an increase in 
birth weight were: being older, having a better education (> 9 years vs ≤ 9 years), having at least one child 
(multipara vs primipara), being male, and having a longer gestation.
In a multiple linear regression model, the deciles of cord blood 25(OH)D were significantly associ-
ated with birth weight, even after adjustment for gestational week, infant gender, prepregnancy BMI, 
gestational weight gain (GWG), birth season, maternal age, education, income, alcohol consumption, 
pregnancy complications, parity, paternal smoking and alcohol consumption. Neonates in four deciles 
(the fourth, fifth, sixth and seventh deciles) had significantly increased birth weight compared with those 
in the lowest decile. The highest adjusted regression coefficients was observed in the fifth decile (β :176.5; 
95% CI: 86.4, 266.5) (Table 3).
Consistently, in a multiple logistic regression model with full adjustment described above (except 
gestational weeks), the deciles of cord blood 25(OH)D were significantly associated with risk of SGA. 
Neonates in four deciles (the fourth, fifth, sixth and seventh deciles) had significantly decreased risk of 
SGA compared with those in the lowest decile, with the lowest adjusted OR observed in the fifth decile 
[0.34 (95% CI 0.14–0.80)] (Table 3). Figure 1 depicts these joint nonlinear associations.
We further assessed the dose-response relation between cord blood 25(OH)D levels and birth weight. 
The inverted U-shaped nature of the association of cord blood 25(OH) D with birth weight was con-
firmed with Gaussian curve-fitting model (P < 0.001). Indeed, this model suggested a significant steep 
increase in birth weight up to 40 nmol/L of cord blood 25(OH)D and a gradual downward trend in birth 
weight at concentrations from 40 to 70 nmol/L, and then level off thereafter (Fig. 2).
Multiple linear regression model shows that per 10 nmol/L increase in cord blood 25(OH)D levels, 
birth weight increased by 61.0 g (95% CI: 31.9, 89.9) at concentrations less than 40 nmol/L, but decreased 
by 68.5 g (95% CI: − 110.5, − 26.6) at concentrations from 40 to 70 nmol/L. We further assessed the dif-
ference of association between cord blood 25(OH)D and birth weight in male and female infants. After 
adjustment for confounders, average birth weight of boys and girls increased by 62.6 g (95% CI: 21.2, 
104.0) and 68.0 g (95% CI: 27.1, 109.0), respectively, per 10 nmol/L increase in cord blood 25(OH)D 
up to 40 nmol/L. However, average birth weight of boys and girls decreased by 58.7 g (95% CI: − 115.9, 
− 1.5) and 82.3 g (95% CI: − 146.5, − 18.1), respectively, per 10 nmol/L increase in cord blood 25(OH)D 
from 40 to 70 nmol/L (Fig. 3).
Discussion
To our knowledge, this is a study with the largest sample examining the association of cord blood 25(OH)
D concentrations with birth weight and the risk of fetal growth restriction. The estimated difference in 
mean of birth weight among neonates in the fifth decile compared with those in the lowest decile was 
around 176 g, greater than the reduction in birth weight observed for children exposed to maternal 
smoking in utero25. Thus, the potential public health implications of our findings are substantial.
Most previous studies in this field were undertaken in developed countries13–15. Compared with North 
American and European countries (the mean 25(OH)D levels of pregnant women in US and UK is 
approximately 50 nmol/L), Asian countries maybe have more pregnant women with vitamin D defi-
ciency13,26–29. For example, the average 25(OH)D level of pregnant women in Beijing (39 °N) was only 
28.6 nmol/L26, which was even lower than the average 25(OH)D levels (39.4 nmol/L) of newborns in 
Hefei (32 °N) reported in our study. However, it should be underlined that the difference on 25(OH)D 
levels may be partly attributed to the different season of blood drawn and assay methods.
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Currently, there is limited information on the association between fetal vitamin D status and fetal 
growth. A small cross-sectional study in China demonstrated that average birth weight was lower in 
newborns (n = 27) with 25(OH)D < 25 nmol/L than those (n = 31) with 25(OH)D ≥ 25 nmol/L26. An 
analysis of 734 neonates in US13 indicated that lower neonatal 25(OH)D were associated with lower birth 
weight-for-gestational age and higher odds of SGA. Another case-control study suggested that infants 
Characteristics
Percentile of 25(OH)D level in cord blood
P-values*
1–10 
(n = 147)
11–20 
(n = 151)
21–30 
(n = 149)
31–40 
(n = 149)
41–50 
(n = 149)
51–60 
(n = 149)
61–70 
(n = 150)
71–80 
(n = 148)
81–90 
(n = 150)
91–100 
(n = 149)
Cord blood 25(OH) , nmol/L)
  Mean (SD) 12.08 (3.07) 19.37 (1.66) 24.50 (1.45) 29.54 (1.43) 34.05 (1.09) 38.58 (1.43) 43.66 (1.58) 50.25 (2.11) 59.34 (3.76) 82.78 (13.99)
 Range 6.06–16.59 16.62–22.17 22.20–27.15 27.18–32.01 32.07–36.03 36.06–41.07 41.10–46.71 46.83–53.85 53.91–66.72 66.78–119.64
Sociodemographic characteristics
  Maternal age, y, 
mean (SD) 27.00 (3.42) 27.72 (3.68) 27.42 (3.51) 28.15 (3.96) 27.74 (3.51) 27.56 (3.42) 27.63 (3.74) 27.93 (3.78) 28.01 (4.02) 27.34 (3.44) 0.067
  Maternal 
education < 9 
years, n (%)
33(22.4) 34(22.5) 33(22.1) 36(24.2) 29(19.5) 24(16.1) 25(16.7) 33(22.3) 29(19.3) 34(22.8) 0.209
  Family monthly 
income 
< 2000 RMB/
yuan, n (%)
27(18.4) 25(16.6) 17(11.4) 21(14.1) 22(14.8) 19(12.8) 25(16.7) 30(20.3) 17(11.3) 22(14.8) 0.613
Perinatal health status
  Prepregnancy 
BMI, mean (SD) 20.20 (2.73) 20.25 (2.27) 20.37 (2.64) 20.10 (2.13) 19.80 (2.36) 20.03 (2.22) 20.04 (2.53) 20.55 (2.57) 20.27 (2.51) 19.97 (2.08) 0.547
  GWG, kg, mean 
(SD) 16.68 (4.63) 17.19 (5.31) 17.43 (5.19) 16.74 (4.47) 16.93 (5.39) 17.02 (5.07) 16.79 (4.59) 17.01 (4.32) 16.24 (4.58) 15.53 (4.73) 0.150
 Multipara, n (%) 15(10.2) 26(17.2) 14(9.4) 22(14.8) 22(14.8) 24(16.1) 22(14.7) 16(10.8) 22(14.7) 133(10.7) 0.637
  Pregnancy 
complicationsa, 
n (%)
23(15.6) 33(21.9) 22(14.8) 28(18.8) 23(15.4) 22(14.8) 18(12.0) 16(10.8) 23(15.3) 18(12.1) 0.055
Prepregnancy lifestyleb
  Maternal alcohol 
consumptionc, 
n (%)
18(12.2) 30(19.9) 17(11.4) 25(16.8) 20(13.4) 25(16.8) 29(19.3) 24(16.2) 22(14.7) 15(10.4) 0.537
  Paternal 
smokingd, n (%) 35(23.8) 29(19.2) 38(25.5) 35(23.5) 27(18.1) 40(26.8) 29(19.3) 35(23.6) 29(19.3) 39(26.2) 0.640
  Paternal alcohol 
consumptionc, 
n (%)
114(77.6) 117(77.5) 127(85.2) 116(77.9) 111(74.5) 120(80.5) 117(78.0) 126(85.1) 127(84.7) 124(83.2) 0.118
Birth outcomes
  Male infant, 
n (%) 62(42.2) 86(57.0) 73(49.0) 80(53.7) 76(51.0) 78(52.3) 85(56.7) 81(54.7) 87(58.0) 83(55.7) 0.027
  Gestational 
weeks, w, mean 
(SD)
38.77 (1.98) 38.68 (1.47) 39.04 (1.37) 39.00 (1.22) 38.93 (1.57) 38.98 (1.41) 38.96 (1.28) 39.13 (1.40) 38.89 (1.29) 38.77 (1.60) 0.204
  Birth weight, g, 
mean (SD)
3235.6 
(533.4)
3351.4 
(455.4)
3382.3 
(452.2)
3447.6 
(412.3)
3460.1 
(435.6)
3452.3 
(475.6)
3436.5 
(416.0)
3412.8 
(437.4)
3342.4 
(441.1)
3310.4 
(425.7) 0.262
  SGA, n (%) 22 (15.0) 17 (11.3) 16 (10.7) 9 (6.0) 8 (5.4) 9 (6.0) 10 (6.7) 11 (7.4) 14 (9.3) 17 (11.4) 0.155
  Birth during 
summer or 
autumn, n (%)
0 (0.0) 17 (11.3) 45 (30.2) 66 (44.3) 85 (57.0) 90 (60.4) 105 (70.0) 116 (78.4) 128 (85.3) 140 (94.0) < 0.001
 Table 1.  Characteristics of the study population across percentile increments of cord blood 25(OH)
D levels. Abbreviation: 25(OH)D, 25-hydroxyvitamin D; BMI, body mass index; GWG, gestational weight 
gain; SGA, small for gestational age. aPregnancy complications included diabetes mellitus, hypertension, 
abnormal heart function, glandula thyreoidea disease, intrahepatic cholestasis of pregnancy, moderate and 
severe anemia. bPrepregnancy lifestyle means lifestyle during up to 6 months before pregnancy. cAlcohol 
consumption was defined as any alcohol consumption. dPaternal smoking was defined as more than 6 
cigarettes daily. *Test for trend based on Mantel-Haenszel chi-square test for categorical variables and linear 
regression for continuous variables.
www.nature.com/scientificreports/
4Scientific RepoRts | 5:14930 | DOi: 10.1038/srep14930
Characteristics n (% 1491) β (95%CI) P value
Sociodemographic characteristics
 Maternal age, y
 20–24 252 (16.9) Reference
 25–29 870 (58.4) 130.2 (67.0, 193.5) < 0.001
 ≥ 30 369 (24.7) 146.4 (70.1, 222.8) < 0.001
Maternal education, education year
 ≤ 9 310 (20.8) Reference
 > 9 1181 (79.2) 87.5 (30.8, 144.2) 0.002
Family monthly income, yuan/RMB
 < 2000 225 (15.1) Reference
 2000–4000 1100 (73.8) 46.2 (− 18.9, 111.3) 0.164
 > 4000 166 (11.1) 104.7 (9.6, 199.8) 0.031
Perinatal health status
Prepregnancy BMI
 Underweight (<18.5) 362 (24.3) − 142.1 (− 195.4, − 88.9) < 0.001
 Normal (18.5–23.9) 1036 (69.5) Reference
 Overweight or obesity (≥ 24.0) 93 (6.2) 184.0 (86.1, 281.8) < 0.001
GWG
 Quartile 1(lowest) 367 (24.6) Reference
 Quartile 2 303 (20.3) 73.5 (3.2, 143.8) 0.040
 Quartile 3 423 (28.4) 217.6 (155.9, 279.4) < 0.001
 Quartile 4(highest) 398 (26.7) 279.9 (217.6, 342.2) < 0.001
Parity
 Primipara 1292 (86.7) Reference
 Multipara 199 (13.3) 76.8 (9.7, 143.8) 0.025
Pregnancy complicationsa
 None 1265 (84.8) Reference
 Yes 226 (15.2) − 3.9 (− 68.2, 60.4) 0.906
Prepregnancy lifestyleb
Maternal alcohol consumption
 None 1266 (84.9) Reference
 Any 225 (15.1) 22.7 (− 41.7, 87.2) 0.489
Paternal smoking
 None 849 (57.0) Reference
 1–5 cigarettes daily 306 (20.5) − 13.5 (− 71.2, 44.2) 0.646
 ≥ 6 cigarettes daily 336 (22.5) − 39.4 (− 97.2, 18.4) 0.181
Paternal alcohol consumption
 None 292 (19.6) Reference
 Any 1199 (80.4) 41.2 (− 16.9, 99.2) 0.165
Birth outcomes
 Infant gender
 Male 791 (53.1) Reference
 Female 700 (46.9) − 129.6 (− 175.3, − 83.8) < 0.001
Gestational weeks
 Full-term (≥ 37 weeks) 1419 (95.2) Reference
 Premature (< 37 weeks) 72 (4.8) − 767.7 (− 860.0, − 667.4) < 0.001
Birth season
 Summer- Autumn 792 (53.1) Reference
 Winter- Spring 699 (46.9) − 5.3 (− 51.6, 40.9) 0.820
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born before 32 wks’ gestation had an increased risk of vitamin D deficiency compared with mature 
infant, however, there was no statistically significant difference in mean cord blood 25(OH)D levels 
between SGA and non-SGA infants29.
Previous studies have several limitations including small sample sizes, inconsistent definitions for fetal 
vitamin D status, few adjustment for confounders and only linear models performed. In this study with 
a large sample, adjustment for more confounders and using non-linear models, we found that there was 
an inverted U-shaped relationship between cord blood 25(OH)D and birth weight, suggesting that the 
newborn with low or high levels of fetal vitamin D are both in increased risk of growth restriction and 
higher levels of fetal vitamin D have not been shown to confer greater benefits. However, it should be 
emphasized that the inverted U shaped relationship in this study does not imply causality, because fetal 
weight would have to have been affected by 25(OH)D at critical times of development rather than at 
birth when samples were collected. Additionally, although there was an inverted U shaped relationship, 
the infants above the seventh decile of 25(OH)D levels still had higher birth weight than those in the 
first decile.
The finding that vitamin D levels in the upper range increased the health risk in this study was 
consistent with previous studies examining the risk of fetal growth restriction11, allergic response30,31, 
lower-extremity function32, frailty status33, as well as cardiovascular disease34,35. Although the neonatal 
25(OH)D levels at birth cannot fully represent the vitamin D status during critical times of gestation 
due to a half-life of several weeks of 25(OH)D34, it was quite possible that the neonates with lower or 
higher cord blood 25(OH)D levels may also have lower or higher average levels of 25(OH)D during 
the whole pregnancy. Therefore, the inverted U shaped relationship in this study maybe suggested that 
gestational vitamin D may have dual biological effects on the fetal growth. However, the biological mech-
anisms remain uncertain. Studies in adults have indicated that there was a U-shaped association between 
25(OH)D and C-reactive protein (CRP), and increasing 25(OH)D concentrations may also be related to 
proinflammatory states36,37. We speculate that fetal exposure to elevated CRP associated with 25(OH)
D in lower or higher range may result in fetal growth restriction38,39, which might explain the inverted 
U-shaped relationship between 25(OH)D levels and fetal growth in this study. However, we cannot rule 
out residual confounding as a potential explanation, especially whether genotypic differences in the study 
population may explain this inverted U-shaped association. Further research is needed to understand 
the mechanisms.
Our study has three major strengths. First, it is the first study reporting that there was an inverted 
U-shaped relationship between cord blood 25(OH)D and fetal growth. Second, prospective data collec-
tion procedure, a relatively large sample size and statistical adjustment for a large number of confounders 
were used. Third, utility of both continuous measure and the deciles of cord blood 25(OH)D concentra-
tions helped to detect the inverted U-shaped relation.
However, several limitations in this study should also be acknowledged. First, we only measured 
25(OH)D concentrations, which is one member of the vitamin D family. At birth, there are potential 
changes to levels of vitamin D binding protein, 1,25(OH)2D, the CYP27 enzyme and expression of 
vitamin D receptors40, which may influence the association between 25(OH)D and fetal growth41. Thus, 
future studies of vitamin D and growth restriction would benefit from the consideration of other vita-
min D family members. Second, 25(OH)D levels at birth cannot represent the vitamin D status in early 
pregnancy. However, we were unable to assess the effect of vitamin D levels during early pregnancy on 
fetal growth as these data are unavailable. Third, the absence of data on outdoor activity, dietary intake, 
environmental factors and genetic variation may result in residual confounding in this study. Finally, this 
study was conducted in one city and caution is necessary in generalizing the findings to other regions 
due to the strong influence of latitude.
In conclusion, this study provides the first epidemiological evidence that there was an inverted U 
shaped relationship between neonatal vitamin D status and fetal growth. The findings suggested that vita-
min D supplements during pregnancy should be encouraged, but with caution. If confirmed in further 
studies, it could have important implications for public health policy.
Methods
Study subjects. This study was conducted on the basis of a prospective birth cohort comprising 2552 
pregnant women recruited in Hefei (32 °N latitude) from January to September 2008. As part of the 
C-ABC study42, pregnant women who received prenatal check-ups in Hefei Maternal and Child Health 
Hospital were recruited by a team of midwives, nurse and health professionals. Participants completed 
a structured questionnaire including sociodemographic characteristics and lifestyle. At birth, midwives 
or study nurses collected the newborn’s anthropometric details and cord blood, when available. In this 
Table 2.  Differences in birth weight according to sociodemographic, health status, lifestyle and birth 
outcomes. Abbreviation: BMI, body mass index; GWG, gestational weight gain. aPregnancy complications 
included diabetes mellitus, hypertension, abnormal heart function, glandula thyreoidea disease, intrahepatic 
cholestasis of pregnancy, moderate and severe anemia. bPrepregnancy lifestyle means lifestyle during up to 6 
months before pregnancy.
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study, stillbirth (n = 11), birth defect (n = 12), women with delivery before 32 weeks of gestation (n = 14), 
pregnancy with assisted reproductive technology (n = 6), or multiple gestations (n = 48) were excluded 
from the study. Finally, we obtained full data including cord blood from 1491 mother-infant pairs. The 
study was approved by the Ethics Committee of the Anhui Medical University. All experiments in this 
study were performed in accordance with the relevant guidelines and regulations and written informed 
consent was obtained from each participants.
Cord blood 25-hydoxyvitamin D. Cord blood sample was collected immediately after delivery and 
anticoagulated by use of sodium heparin. Plasma samples were centrifuged and promptly refrigerated at 
− 4 °C, within 12 h, transferred to − 80 °C freezers for long-term storage. 25(OH)D concentrations were 
measured using the commercial radioimmunoassay kits (DiaSorin Stillwater, MN, USA). Intra-assay and 
inter-assay coefficients of variation were 8.8% and 11.1% respectively. Plasma concentrations of 25(OH)
D were analyzed both as a continuous variable and a decile.
Cord Blood 25(OH)D 
Levels (nmol/L)
n
Birth Weight SGA
Partially Adjusteda Fully Adjustedb Partially Adjusteda Fully Adjustedb
Percentile Mean (SD) β (95% CI) P-values β (95% CI) P-values OR (95% CI) P-values OR (95% CI) P-values
1–10 12.08 (3.07) 147 Reference Reference Reference Reference
11–20 19.37 (1.66) 151 96.1 (− 0.8, 192.9) 0.052 84.1 (− 12.7, 181.0) 0.089 0.77 (0.39, 1.52) 0.452 0.79 (0.39, 1.58) 0.500
21–30 24.50 (1.45) 149 108.5 (14.5, 202.4) 0.024 94.4 (− 0.1, 189.2) 0.050 0.71 (0.35, 1.41) 0.324 0.73 (0.36, 1.46) 0.371
31–40 29.54 (1.43) 149 170.6 (76.0, 265.1) < 0.001 150.0 (53.0, 246.1) 0.002 0.38 (0.17, 0.86) 0.021 0.40 (0.18, 0.92) 0.030
41–50 34.05 (1.09) 149 189.1 (99.8, 278.4) < 0.001 176.5 (86.4, 266.5) < 0.001 0.33 (0.14, 0.77) 0.010 0.34 (0.14, 0.80) 0.013
51–60 38.58 (1.43) 149 161.6 (67.9, 255.3) 0.001 151.4 (56.9, 245.9) 0.002 0.38 (0.17, 0.86) 0.020 0.41 (0.18, 0.93) 0.033
61–70 43.66 (1.58) 150 161.2 (67.7, 254.7) 0.001 147.8 (52.8, 242.7) 0.002 0.42 (0.19, 0.93) 0.032 0.44 (0.20, 0.97) 0.042
71–80 50.25 (2.11) 148 92.2 (− 4.7, 189.1) 0.062 66.2 (− 30.0, 162.5) 0.177 0.49 (0.23, 1.06) 0.072 0.53 (0.24, 1.14) 0.105
81–90 59.34 (3.76) 150 56.9 (− 34.4, 148.2) 0.221 46.5 (− 45.6, 138.6) 0.321 0.63 (0.31, 1.28) 0.201 0.73 (0.35, 1.51) 0.400
91–100 82.78 (13.99) 149 49.6 (− 46.9, 146.1) 0.313 23.5 (− 74.4, 121.4) 0.637 0.78 (0.40, 1.55) 0.485 0.84 (0.42, 1.69) 0.631
Table 3.  Associations of cord blood 25(OH)D levels with birth weight and the risk of SGA. 
Abbreviation: 25(OH)D, 25-hydroxyvitamin D; BMI, body mass index; GWG, gestational weight gain; 
SGA, small for gestational age. aAdjusted for gestational week, infant gender, prepregnancy BMI, GWG 
and birth season. bFurther adjusted for maternal age, education, income, alcohol consumption, pregnancy 
complications, parity, paternal smoking and alcohol consumption additionally.
Figure 1. Fully adjusted regression coefficients (A) for birth weight and odd ratios (B) of small 
for gestational age across the deciles of cord blood 25(OH)D concentrations. Adjusted gestational 
week, infant gender, prepregnancy BMI, GWG, birth season, maternal age, education, income, alcohol 
consumption, pregnancy complications, parity, paternal smoking and alcohol consumption. D1, D2 and D3 
means the first, second and third decile of cord blood 25(OH)D respectively, and so on. The dotted line 
represents the trend for the point estimate.
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Outcomes variables. The key outcomes assessed in this study included birth weight and SGA defined 
as birth weight < 10th percentiles of distribution for gestational age and infant gender43. The accuracy of 
scales used to measure birth weight in the hospital was checked using standard weights at the beginning 
of the study and every 3 months thereafter.
Potential confounders. The most important potential confounder was gestational age, infants 
gender, prepregnancy body mass index (BMI), GWG and birth season, which have been known to be 
associated with birth weight or maternal 25(OH)D levels15,44. The gestational age (in completed weeks) 
based on the difference between the date of the last menstrual period and the date of delivery and was 
categorized as < 37 or ≥ 37 gestational weeks. Prepregnancy BMI was calculated on the basis of the 
height routinely measured at the clinic visit and on the self-reported prepregnancy weight obtained 
at interview and were categorized as underweight (< 18.5), normal weight (18.5–23.9), or overweight 
or obese (≥ 24.0)45. The absolute amount of weight gained throughout pregnancy was determined by 
subtracting the self-reported prepregnancy weight at interview from the measured weight recorded at 
the last prenatal visit before delivery, categorized based on quartiles. Birth season was designated as: 
winter (December, January, February), spring (March, April, May), summer (June, July, August), or fall 
(September, October, November). Other potential confounders included maternal age (20–24, 25–29 and 
30 and more years), education (≤ 9 and > 9 years of completed schooling), household income (less than 
2000, 2000–4000 and more than 4000 RMB), parity (primipara or multipara), pregnancy complications, 
maternal alcohol consumption during pregnancy (any or no), paternal alcohol consumption (any or no) 
and smoking (none, 1–5, 6 or more cigarettes daily) during pregnancy.
Figure 2. Unadjusted association of cord blood 25(OH)D concentrations and birth weight using 
Gaussian curve-fitting model with knot at 40 nmol/L (P < 0.001). The solid line represents the trend for 
changes in birth weight in mean values across increasing cord blood 25(OH)D concentrations and dotted 
lines represent the 95% confidence interval.
Figure 3. Adjusted linear regression associations between cord blood 25(OH)D concentrations and birth 
weight at 25(OH)D < 40 nmol/L and from 40 to 70 nmol/L according to infant gender. The solid line 
represents the linear regression trend for the change of birth weight in mean values across increasing cord 
blood 25(OH)D concentrations.
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Statistical analysis. Cord blood 25(OH)D concentrations were divided into deciles. General linear 
regression models and Mantel-Haenszel chi-square test were used to compare means and proportions for 
the characteristics of pregnancy women across the deciles of 25(OH)D level. The means of the deciles 
were fit as continuous variables to estimate the trend of variables across deciles in a linear regression 
model. Differences of birth weight according to maternal characteristics were evaluated using linear 
regression models.
The adjusted regression coefficients of multiple linear regression models were generated for the asso-
ciation between the deciles of 25(OH)D levels and birth weight, that were adjusted for gestational week, 
infant gender, prepregnancy BMI, GWG and birth season, and further adjusted for maternal age, edu-
cation, income, alcohol consumption, pregnancy complications, parity, paternal smoking and alcohol 
consumption. Multivariable logistic regression models were used to determine odd ratios (OR) and 95% 
CIs for SGA after adjusting for confounders as described above.
The curvilinear association between 25(OH)D and birth weight was best described using a Gaussian 
curve-fitting model46 with knot at 40 nmol/L. Then, adjusted regression coefficients of linear regression 
model were generated for the association between 25(OH)D and birth weight according to 25(OH)D 
level with knot at 40 nmol/L. Furthermore, the data were stratified by infant gender. All statistical anal-
yses were performed using SPSS statistical software, version 21.0.
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